874880-58-7 Usage
Uses
Used in Pharmaceutical Industry:
4-Amino-3-bromo-5-fluorobenzonitrile is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 4-Amino-3-bromo-5-fluorobenzonitrile is utilized as a precursor in the production of agrochemicals, potentially enhancing crop protection and yield.
Used in Chemical Research and Development:
4-Amino-3-bromo-5-fluorobenzonitrile serves as a building block for more complex molecules in chemical research and development, facilitating the creation of advanced organic compounds for various applications.
Used in Production of Dyes:
4-Amino-3-bromo-5-fluorobenzonitrile has potential applications in the production of dyes, where its unique structure can contribute to the development of novel colorants for different industries.
Used in Other Chemical Products:
Due to its reactivity and chemical properties, 4-Amino-3-bromo-5-fluorobenzonitrile is also used in the manufacturing of other chemical products, expanding its utility across various sectors.
It is crucial to handle 4-Amino-3-bromo-5-fluorobenzonitrile with care due to its potential hazards and toxicity, ensuring safety in all applications.
Check Digit Verification of cas no
The CAS Registry Mumber 874880-58-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,4,8,8 and 0 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 874880-58:
(8*8)+(7*7)+(6*4)+(5*8)+(4*8)+(3*0)+(2*5)+(1*8)=227
227 % 10 = 7
So 874880-58-7 is a valid CAS Registry Number.
874880-58-7Relevant academic research and scientific papers
HETEROCYCLIC COMPOUNDS AND USE THEREOF AS MODULATORS OF TYPE III RECEPTOR TYROSINE KINASES
-
Paragraph 0906, (2016/08/03)
Provided herein are heterocyclic compounds for treatment of CSF1R, FLT3, KIT, and/or PDGFRβ kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
TRPV4 ANTAGONISTS
-
Page/Page column 77, (2013/02/28)
The present invention relates to spirocarbamate analogs, pharmaceutical compositions containing them and their use as TRPV4 antagonists.
